Medicamen Biotech sets Sep 19 2026 as record date for Re 1 final dividend
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 3.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medicamen Biotech Board fixed September 19, 2026 as the record or cut-off date for its proposed final dividend of 10 percent, equal to Re 1 per equity share of Rs 10 face value, for FY 2025-26. The 33rd Annual General Meeting is scheduled for September 26, 2026 at 12 noon through video conferencing. Register of Members and share transfer books will remain closed from September 19 to September 25, 2026. Dividend payment is subject to shareholder approval at the AGM.
Investors holding shares as of September 19, 2026 will receive a Re 1 per share final dividend if approved at the AGM on September 26, 2026.